Symposium of the Biological Development Center

The development of innovative biologicals often stalls at the transition from academic discovery to clinical application.

The Biologicals Development Center, established by NMI and WSIC with EFRE support, aims to address this challenge by providing comprehensive infrastructure and expertise for the design, production, functionalization, and evaluation of biologicals across therapeutic, diagnostic, and biofunctional domains.

This workshop offers insights into scientific, technological, and manufacturing challenges that shape the future of biologicals. The program includes contributions from the project’s steering committee and invited industry partners.

In addition, the current status of the Center will be presented demonstrating how shared analytical capabilities and structured developability approaches can accelerate early biologicals development.

Together, we explore how coordinated resources and cross‑sector collaboration can strengthen regional innovation and enable biologicals to reach real‑world application faster.

Time:

9 a.m. to 1 p.m.

Presentations by:

Prof. Dr. Johannes Schwenck (Universitätsklinikum Tübingen): Clinical Molecular Imaging - State of the Art and Future Trends

Prof. Dr. Margret Schottelius (Universität Lausanne): Imaging the TME - Opportunities and Challenges

Thilo Grob (Rentschler Biopharma): Trends in Biological Manufacturing

Thomas Schmid (Fraunhofer IZI): From Research to GMP: What Really Breaks – and How to Fix It

Dr. Jan Chemnitz (Provirex): The Future of HIV Therapy; PROVIREX Technology: Error-free Genome Editing

Dr. Anne Zeck (NMI): Developability of Nanobody Tracers

Dr. Jörg Regula (Boehringer Ingelheim): From Quality Control to Structure Function Relations

Dr. Michael Molhoj (Immatics): Mass Spec Analysis at NMI for the CMC Development of TCR Bispecifics (TCER®)

Flyer

Registration closed.